Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort (Q33937634)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Monique Roobol

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Hans Lilja

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

10

Jonas Hugosson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Tineke Wolters

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Caroline J Savage

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Angel M Cronin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

M Frank O'Brien

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Kim Pettersson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Gunnar Aus

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Peter T Scardino

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Fritz H Schröder

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

7 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

753-760

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

Prostate cancer: estimating the benefits of PSA screening

5 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891354

Screening and prostate-cancer mortality in a randomized European study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891354

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891354

Relationship of prostate-specific antigen velocity to histologic findings in a prostate cancer screening program

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891354

Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891354

Early detection of prostate cancer in 2007. Part 1: PSA and PSA kinetics.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891354

Assessment of prostate-specific antigen doubling time in prediction of prostate cancer on needle biopsy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891354

Decision curve analysis: a novel method for evaluating prediction models

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891354

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891354

Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891354

Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891354

Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891354

Assessment of diagnostic tests when disease verification is subject to selection bias

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891354

Prostate specific antigen assay standardization bias could affect clinical decision making.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891354

Is prostate-specific antigen velocity useful in early detection of prostate cancer? A critical appraisal of the evidence

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891354

Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab')2 fragments.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891354

Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891354

Reference reagents for prostate-specific antigen (PSA): establishment of the first international standards for free PSA and PSA (90:10)

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891354

Effect of Finasteride on the Sensitivity of PSA for Detecting Prostate Cancer

29 October 2018

1 reference

12 December 2020

PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section

1 reference

12 December 2020

Prediagnostic prostate-specific antigen velocity and probability of detecting high-grade prostate cancer

1 reference

12 December 2020

EAU guidelines on prostate cancer

1 reference

12 December 2020

Is the utility of prostate-specific antigen velocity for prostate cancer detection affected by age?

1 reference

12 December 2020

Optimal measure of PSA kinetics to identify prostate cancer

1 reference

12 December 2020

The utility of prostate-specific antigen velocity thresholds in clinical practice: a population-based analysis

1 reference

12 December 2020

Total Prostate Specific Antigen Stability Confirmed After Long-Term Storage of Serum at −80C

1 reference

12 December 2020

10.1016/J.EURURO.2009.07.047

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

release_qna3h75m7bb5ddg756nw52w34e

5 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qna3h75m7bb5ddg756nw52w34e

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19682790%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

PubMed publication ID

19682790

1 reference